Cambridge, MA, December 6, 2022 (Reuters) -- Summit Therapeutics Inc (SMMT.O) said on Tuesday it would license China-based Akeso Inc's (9926.HK) experimental cancer therapy in a deal worth up to $5 billion, sending its shares up 57% in premarket trade.
Read full article here.
Boundless Bio Secures $100M Series C Funding to Advance ecDNA-Directed Therapies for Oncogene Cancer
San Diego, CA, May 16, 2023 (Business Wire) -- Boundless Bio, a pioneering precision oncology company, has successfully raised $100 million in a Series C financing round led by Leaps by Bayer and RA
Sunnyvale, CA, May 23, 2023 (Cepheid) -- Cepheid, a renowned molecular diagnostics company, has appointed Vitor Rocha as its new President. With over 20 years of experience in the medical devices in
Cambridge, MA, May 23, 2023 (Business Wire) -- ReNAgade Therapeutics, a cutting-edge company focused on harnessing the full potential of RNA medicines for disease correction, has successfully raised
